RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer
2008-01-01 Ladu, S; Calvisi, Diego Francesco; Conner, Ea; Farina, M; Factor, Vm; Thorgeirsson, Ss
Early Subcellular Hepatocellular Alterations in Mice Post Hydrodynamic Transfection: An Explorative Study
2023-01-01 Yasser, M.; Ribback, S.; Evert, K.; Utpatel, K.; Annweiler, K.; Evert, M.; Dombrowski, F.; Calvisi, D. F.
EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.
2014-01-01 Pellegrino, R; Calvisi, Diego Francesco; Neumann, O; Kolluru, V; Wesely, J; Chen, X; Wang, C; Wuestefeld, T; Ladu, S; Elgohary, N; Bermejo, Jl; Radlwimmer, B; Zörnig, M; Zender, L; Dombrowski, F; Evert, M; Schirmacher, P; Longerich, T.
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
2018-01-01 Dong, M.; Liu, X.; Evert, K.; Utpatel, K.; Peters, M.; Zhang, S.; Xu, Z.; Che, L.; Cigliano, A.; Ribback, S.; Dombrowski, F.; Cossu, A.; Gordan, J.; Calvisi, D. F.; Evert, M.; Liu, Y.; Chen, X.
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma
2023-01-01 Steinmann, S. M.; Sanchez-Martin, A.; Tanzer, E.; Cigliano, A.; Pes, G. M.; Simile, M. M.; Desaubry, L.; Marin, J. J. G.; Evert, M.; Calvisi, D. F.
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression.
2012-01-01 Frau, M; Tomasi, Ml; Simile, Maria Maddalena; Salis, F; Latte, Gavinella; Calvisi, Diego Francesco; Seddaiu, Ma; Daino, L; Cf, Feo; Brozzetti, S; Yamashita, S; Ushijima, T; Feo, F; Pascale, Rosa Maria; Solinas, Maria Giuliana
Experimental models to define the genetic predisposition to liver cancer
2019-01-01 Pascale, R. M.; Simile, M. M.; Peitta, G.; Seddaiu, M. A.; Feo, F.; Calvisi, D. F.
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma
2019-01-01 Vicent, S.; Lieshout, R.; Saborowski, A.; Verstegen, M. M. A.; Raggi, C.; Recalcati, S.; Invernizzi, P.; van der Laan, L. J. W.; Alvaro, D.; Calvisi, D. F.; Cardinale, V.
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
2016-01-01 Banales, Jesus M; Cardinale, Vincenzo; Carpino, Guido; Marzioni, Marco; Andersen, Jesper B.; Invernizzi, Pietro; Lind, Guro E.; Folseraas, Trine; Forbes, Stuart J.; Fouassier, Laura; Geier, Andreas; Calvisi, Diego Francesco; Mertens, Joachim C.; Trauner, Michael; Benedetti, Antonio; Maroni, Luca; Vaquero, Javier; Macias, Rocio I. R.; Raggi, Chiara; Perugorria, Maria J.; Gaudio, Eugenio; Boberg, Kirsten M.; Marin, Jose J. G.; Alvaro, Domenico
Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development
2021-01-01 Pocaterra, A.; Scattolin, G.; Romani, P.; Ament, C.; Ribback, S.; Chen, X.; Evert, M.; Calvisi, D. F.; Dupont, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer | 1-gen-2008 | Ladu, S; Calvisi, Diego Francesco; Conner, Ea; Farina, M; Factor, Vm; Thorgeirsson, Ss | |
| Early Subcellular Hepatocellular Alterations in Mice Post Hydrodynamic Transfection: An Explorative Study | 1-gen-2023 | Yasser, M.; Ribback, S.; Evert, K.; Utpatel, K.; Annweiler, K.; Evert, M.; Dombrowski, F.; Calvisi, D. F. | |
| EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma. | 1-gen-2014 | Pellegrino, R; Calvisi, Diego Francesco; Neumann, O; Kolluru, V; Wesely, J; Chen, X; Wang, C; Wuestefeld, T; Ladu, S; Elgohary, N; Bermejo, Jl; Radlwimmer, B; Zörnig, M; Zender, L; Dombrowski, F; Evert, M; Schirmacher, P; Longerich, T. | |
| Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model | 1-gen-2018 | Dong, M.; Liu, X.; Evert, K.; Utpatel, K.; Peters, M.; Zhang, S.; Xu, Z.; Che, L.; Cigliano, A.; Ribback, S.; Dombrowski, F.; Cossu, A.; Gordan, J.; Calvisi, D. F.; Evert, M.; Liu, Y.; Chen, X. | |
| eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma | 1-gen-2023 | Steinmann, S. M.; Sanchez-Martin, A.; Tanzer, E.; Cigliano, A.; Pes, G. M.; Simile, M. M.; Desaubry, L.; Marin, J. J. G.; Evert, M.; Calvisi, D. F. | |
| Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. | 1-gen-2012 | Frau, M; Tomasi, Ml; Simile, Maria Maddalena; Salis, F; Latte, Gavinella; Calvisi, Diego Francesco; Seddaiu, Ma; Daino, L; Cf, Feo; Brozzetti, S; Yamashita, S; Ushijima, T; Feo, F; Pascale, Rosa Maria; Solinas, Maria Giuliana | |
| Experimental models to define the genetic predisposition to liver cancer | 1-gen-2019 | Pascale, R. M.; Simile, M. M.; Peitta, G.; Seddaiu, M. A.; Feo, F.; Calvisi, D. F. | |
| Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma | 1-gen-2019 | Vicent, S.; Lieshout, R.; Saborowski, A.; Verstegen, M. M. A.; Raggi, C.; Recalcati, S.; Invernizzi, P.; van der Laan, L. J. W.; Alvaro, D.; Calvisi, D. F.; Cardinale, V. | |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | 1-gen-2016 | Banales, Jesus M; Cardinale, Vincenzo; Carpino, Guido; Marzioni, Marco; Andersen, Jesper B.; Invernizzi, Pietro; Lind, Guro E.; Folseraas, Trine; Forbes, Stuart J.; Fouassier, Laura; Geier, Andreas; Calvisi, Diego Francesco; Mertens, Joachim C.; Trauner, Michael; Benedetti, Antonio; Maroni, Luca; Vaquero, Javier; Macias, Rocio I. R.; Raggi, Chiara; Perugorria, Maria J.; Gaudio, Eugenio; Boberg, Kirsten M.; Marin, Jose J. G.; Alvaro, Domenico | |
| Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development | 1-gen-2021 | Pocaterra, A.; Scattolin, G.; Romani, P.; Ament, C.; Ribback, S.; Chen, X.; Evert, M.; Calvisi, D. F.; Dupont, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 203
- 1 Contributo su Rivista::1.1 Arti... 203
Data di pubblicazione
- In corso di stampa 2
- 2020 - 2024 52
- 2010 - 2019 102
- 2000 - 2009 43
- 1998 - 1999 4
Editore
- BMJ Group 1
- The American Society for Clinical... 1
Rivista
- HEPATOLOGY 34
- JOURNAL OF HEPATOLOGY 17
- ONCOTARGET 11
- CANCER RESEARCH 9
- GASTROENTEROLOGY 7
- CARCINOGENESIS 6
- LIVER INTERNATIONAL 6
- THE AMERICAN JOURNAL OF PATHOLOGY 6
- CANCERS 5
- INTERNATIONAL JOURNAL OF CANCER 5
Keyword
- Humans 20
- Animals 17
- Hepatocellular carcinoma 16
- hepatocellular carcinoma 16
- Liver Neoplasms 16
- Mice 16
- Carcinoma 14
- Hepatocellular 14
- Hepatology 14
- Cholangiocarcinoma 12
Lingua
- eng 201
- ger 1
Accesso al fulltext
- no fulltext 188
- open 15